Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 1, 2009, Pages 66-79

  Carls, Ginger ^a,g   Li, Tracy ^d   Panopalis, Pantelis ^e   Wang, Shaohung ^b   Mell, Amy G ^a   Gibson, Teresa B ^a   Goetzel, Ron Z ^c,f  

^a MEDSTAT GROUP   (United States)

^b Thomson Healthcare   (United States)

^c Health and Productivity Research   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f EMORY UNIVERSITY   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILLING AND CLAIMS; CHRONIC DISEASE; CONTROLLED STUDY; DISABILITY; EMPLOYEE; EMPLOYER; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PRODUCTIVITY; SYSTEMIC LUPUS ERYTHEMATOSUS; ABSENTEEISM; ADOLESCENT; CASE CONTROL STUDY; CHILD; COST OF ILLNESS; ECONOMICS; HEALTH INSURANCE; INSURANCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL LEAVE; MIDDLE AGED; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INSURANCE CLAIM REPORTING; INSURANCE, HEALTH; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SICK LEAVE; UNITED STATES; YOUNG ADULT;

EID: 66749176262     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31818a405a     Document Type: Article

References (27)

1. Agrawal N, Chiang LK, Rifkin IR. Lupus nephritis. Semin Nephrol. 2006;26:95-104.
2. Mok CC. Prognostic factors in lupus nephritis. Lupus. 2005;14:39-44.
3. Thorp ML, Eastman L, Smith DH, Johnson ES. Managing the burden of chronic kidney disease. Dis Manag. 2006;9:115-121.
4. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308-318.
5. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin. 2002;16:847-858.
6. Kozora E, Ellison MC, West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis Rheum. 2006;55:628-635.
7. Partridge AJ, Karlson EW, Daltroy LH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum. 1997;40:2199-2206.
8. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993;36:1548-1559.
9. Clarke AE, Petri MA, Manzi S, et al. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. J Rheumatol. 1999;26:1500-1511.
10. Clarke AE, Petri M, Manzi S, et al. The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology. 2004;43:1016-1024.
11. Panopalis P, Petri M, Manzi S, et al. The systemic lupus erythematosus Tri-nation Study: cumulative indirect costs. Arthritis Rheum. 2007;57:64-70.
12. Brunner HI, Sherrard TM, Klein-Gitelman MS. Cost of treatment of childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006;55:184-188.
13. Nichol MB, Shi S, Knight TK, Wallace DJ, Weisman MH. Eligibility, utilization, and costs in a California Medicaid lupus population. Arthritis Rheum. 2004;51: 996-1003.
14. Miller ME, Sulvetta MB, Englert E. Service mix in the hospital outpatient department: implications for Medicare payment reform. Health Serv Res. 1995;30:59-78.
15. Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000; 34:1351-1362.
16. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. German Collaborative Arthritis Centres. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65:1175-1183.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
18. Yelin E, Trupin L, Katz P, et al. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. Arthritis Rheum. 2007;57: 508-515.
19. Parsons LS. Reducing Bias in a Propensity Score Matched-pair Sample Using Greedy Matching Techniques. SUGI 26 Proceedings; 2001:214-226.
20. Michael T, King G, Zeng L. Relogit: rare events logistic regression. J Stat Softw. 2003;8:246-247.
21. Goetzel R, Guindon A, Turshen I, Ozminkowski R. Health and productivity management: establishing key performance measures, benchmarks, and best practices. J Occup Environ Med. 2001;43:10.
22. Goetzel R, Hawkins K, Ozminkowski R, Wang S. The health and productivity cost burden of the 'top-10' physician and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5-14.
23. Goetzel RZ, Long SR, Ozminkowski R, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. J Occup Environ Med. 2004;46:398-412.
24. Ozminkowski RJ, Burton WN, Goetzel RZ, Maclean R, Wang S. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med. 2006;48:135-148.
25. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med. In press.
26. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology. 2001;40:37-47.
27. Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49: 368-374.